Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Mayo Clinic Laboratories, |
RCV001699952 | SCV002541966 | uncertain significance | not provided | 2021-12-16 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002496018 | SCV002776042 | uncertain significance | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J; Tibial muscular dystrophy; Myopathy, myofibrillar, 9, with early respiratory failure; Early-onset myopathy with fatal cardiomyopathy; Hypertrophic cardiomyopathy 9 | 2021-12-06 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV001699952 | SCV003823652 | uncertain significance | not provided | 2020-04-03 | criteria provided, single submitter | clinical testing | |
Clinical Genetics, |
RCV001699952 | SCV001921194 | uncertain significance | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001699952 | SCV001967590 | uncertain significance | not provided | no assertion criteria provided | clinical testing |